Proteomic analysis of vitreous from diabetic macular edema.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Experimental Eye Research

• Publication date

  2005-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.EXER.2005.01.020PMID 16080911
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein Database, Human Retinal Pigment Epithelium*

  2003cited by this paper
• Apolipoprotein H Gene Polymorphisms and Risk of Primary Cerebral Hemorrhage in a Chinese Population

  2003cited by this paper
• Proteome Analysis of Human Vitreous Proteins*

  2003cited by this paper
• Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders.

  2002cited by this paper
• Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration.

  2002cited by this paper
• Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema.

  2002cited by this paper
• Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole.

  2002cited by this paper
• Drusen proteome analysis: An approach to the etiology of age-related macular degeneration

  2002cited by this paper
• [Cytokines in the vitreous fluid of patients with proliferative diabetic retinopathy--vascular endothelial growth factor and platelet-derived growth factor are elevated in proliferative diabetic retinopathy].

  2001cited by this paper
• Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment.

  2001cited by this paper
• IMPROVED VISUAL ACUITY FOLLOWING PARS PLANA VITRECTOMY FOR DIABETIC CYSTOID MACULAR EDEMA AND DETACHED POSTERIOR HYALOID

  2000cited by this paper
• The pathogenesis of edema in diabetic maculopathy.

  1999cited by this paper
• Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.

  1998cited by this paper
• Proteolytic activity directed toward pigment epithelium-derived factor in vitreous of bovine eyes. Implications of proteolytic processing.

  1996cited by this paper
• Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.

  1996cited by this paper
• Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.

  1995cited by this paper
• Erythropoietin in diabetic macular edema and renal insufficiency.

  1995cited by this paper
• Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats.

  1993cited by this paper
• Ocular problems in diabetes mellitus

  1992cited by this paper
• Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction.

  1992cited by this paper
• Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results.

  1991cited by this paper
• Posterior precortical vitreous pocket.

  1991cited by this paper
• Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells.

  1989cited by this paper
• Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

  1985cited by this paper

• Identification of unique biomarkers for proliferative diabetic retinopathy with tractional retinal detachment by proteomics profiling of vitreous humor

  2025cites this paper
• Comparative Tear Fluid Proteomics to Explore Treatment Responsiveness in Diabetic Macular Edema: A Pilot Study

  2025cites this paper
• Tear Protein Markers for Diabetic Retinopathy and Diabetic Macular Edema – Towards an Early Diagnosis and Better Prognosis

  2024cites this paper
• Proteomic analysis of aqueous humor reveals novel regulators of diabetic macular edema.

  2023cites this paper
• Loss-Modified Transformer-Based U-Net for Accurate Segmentation of Fluids in Optical Coherence Tomography Images of Retinal Diseases

  2023cites this paper
• Comparative proteomics of proliferative diabetic retinopathy in people with Type 2 diabetes highlights the role of inflammation, visual transduction, and extracellular matrix pathways

  2023cites this paper
• A systematic proteomic profiling and pathway analysis of protein biomarkers in diabetic retinopathy with subsequent validation of the IL-6 upstream regulator

  2023cites this paper
• Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications

  2022cites this paper
• Proteomic analysis of vitreous humour of eyes with diabetic macular oedema: a systematic review

  2022influential citation
• Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases

  2022cites this paper
• Aqueous Humor Apolipoprotein Concentration and Severity of Diabetic Retinopathy in Type 2 Diabetes

  2022cites this paper
• Effect of aflibercept on proliferative vitreoretinopathy: Proteomic analysis in an experimental animal model.

  2021cites this paper
• Analytical Strategy for MS-Based Thanatochemistry to Estimate Postmortem Interval.

  2021cites this paper
• Diabetic Macular Edema

  2021cites this paper
• Intra-population differences of apolipoproteins in the aqueous humor

  2021cites this paper
• Nanomedicine for Treating Diabetic Retinopathy Vascular Degeneration

  2021cites this paper
• Assessment of biomarkers associated with rapid renal decline in the detection of retinopathy and its progression in type 2 diabetes: The Fremantle Diabetes Study Phase II.

  2021cites this paper
• The Vitreous Ecosystem in Diabetic Retinopathy: Insight into the Patho-Mechanisms of Disease

  2021cites this paper
• Benefits of micronutrient supplementation for reducing the risk of wet age-related macular disease and diabetic retinopathy

  2020cites this paper
• Association between vitamin-D deficiency with the presence and severity of diabetic retinopathy in type-2 diabetes mellitus

  2020cites this paper
• Vitreous Antioxidants, Degeneration, and Vitreo-Retinopathy: Exploring the Links

  2019cites this paper
• Pathophysiology and Management of Diabetic Retinopathy Features

  2019cites this paper
• Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy

  2019cites this paper
• Characterization of low molecular weight urinary proteins at varying time intervals in type 2 diabetes mellitus and diabetic nephropathy patients

  2019cites this paper
• Paenibacillus terrae NK3-4: A potential biocontrol agent that produces β-1,3-glucanase

  2019cites this paper
• Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis

  2018cites this paper
• Proteomics of Neurodegenerative Disorders of the Eye

  2018cites this paper
• Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases

  2018cites this paper
• iTRAQ Quantitative Proteomic Analysis of Vitreous from Patients with Retinal Detachment

  2018cites this paper
• Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy.

  2017cites this paper
• Pharmacokinetic aspects of retinal drug delivery.

  2017cites this paper
• A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders

  2017influential citation
• Prediction of intraocular antibody drug stability using ex‐vivo ocular model

  2017cites this paper
• Omics Biomarkers in Ophthalmology.

  2017cites this paper
• Serum 25-hydroxyvitamin D levels and diabetic retinopathy : a systematic meta-analysis

  2016cites this paper
• Differential Expression of Vitreous Proteins in Young and Mature New Zealand White Rabbits

  2016cites this paper
• Selection Strategy of In Vivo Models for Ophthalmic Drug Development in Diabetic Retinopathy

  2016cites this paper
• Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC–MS/MS and iTRAQ quantification

  2015cites this paper
• Evaluation of protein drug stability with vitreous humor in a novel ex-vivo intraocular model.

  2015cites this paper
• Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence.

  2015cites this paper
• Quantitative Proteomics Analysis of Vitreous Humor from Diabetic Retinopathy Patients.

  2015cites this paper
• Vitreous humor in the pathologic scope: Insights from proteomic approaches

  2015cites this paper
• Proteomic Analysis of Embryonic and Young Human Vitreous.

  2015cites this paper
• Diabetic macular edema: new concepts in patho-physiology and treatment

  2014cites this paper
• Proteomic analysis of human vitreous humor

  2014cites this paper
• Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo.

  2014cites this paper
• Trends in proteomic analysis of human vitreous humor samples

  2014cites this paper
• Vitreous proteomic analysis of idiopathic epiretinal membranes.

  2014cites this paper
• Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis

  2014cites this paper
• Proteomic techniques for the discovery of biomarkers associated with uveal melanoma and cutaneous melanoma disease progression

  2014cites this paper
• Top-down peptidomics of bodily fluids

  2014influential citation
• Identification of new pathogenic candidates for diabetic macular edema using fluorescence‐based difference gel electrophoresis analysis

  2013cites this paper
• The Human Eye Proteome Project: Perspectives on an emerging proteome

  2013cites this paper
• Quantitative proteomics of aqueous and vitreous fluid from patients with idiopathic epiretinal membranes.

  2013cites this paper
• Proteomic Analyses of the Vitreous Humour

  2012influential citation
• Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis.

  2012cites this paper
• Study of Diabetic Hypertensive Nephropathy in the Local Population of Pakistan

  2012cites this paper
• Characterisation of the vitreous proteome in proliferative diabetic retinopathy

  2012cites this paper
• Biomarker Identification of Vitreous Fluid for Diabetic Retinopathy

  2012cites this paper
• Pilot application of iTRAQ to the retinal disease Macular Telangiectasia.

  2012cites this paper
• Proteomic analysis and identification of aqueous humor proteins with a pathophysiological role in diabetic retinopathy.

  2012cites this paper
• Proteome‐base biomarkers in diabetes mellitus: Progress on biofluids' protein profiling using mass spectrometry

  2012influential citation
• Usefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic Retinopathy

  2012cites this paper
• Proteomics in the Vitreous of Diabetic Retinopathy Patients

  2012cites this paper
• Complement involvement in neovascular ocular diseases.

  2012cites this paper
• Mass spectrometry‐based characterization of the vitreous phosphoproteome

  2010cites this paper
• Vitreous Proteomics and Diabetic Retinopathy

  2010cites this paper
• Ocular Proteomics with Emphasis on Two-Dimensional Gel Electrophoresis and Mass Spectrometry

  2009cites this paper
• Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema

  2009cites this paper
• Human retinal pigment epithelium proteome changes in early diabetes

  2008cites this paper
• Vitreous proteomic analysis of proliferative vitreoretinopathy

  2008cites this paper
• Proteome profiling of vitreoretinal diseases by cluster analysis

  2008cites this paper
• Diabetic Macular Edema

  2008cites this paper
• Proteomics as a research tool in clinical and experimental ophthalmology

  2008influential citation
• Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.

  2008cites this paper
• Therapeutic Agents for Posterior Segment Vitrectomy Surgery

  2008cites this paper
• Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.

  2008cites this paper
• Application of proteomic technology in eye research: a mini review

  2008influential citation
• Diabetic Retinopathy: From Pathogenesis to Treatment

  2008cites this paper
• Identification of phosphotyrosyl proteins in vitreous humours of patients with vitreoretinal diseases by sodium dodecyl sulphate–polyacrylamide gel electrophoresis/Western blotting/matrix-assisted laser desorption time-of-flight mass spectrometry

  2008cites this paper
• Inflammatory cystoid macular edema

  2007cites this paper
• Retinal Mueller glial cells trigger the hallmark inflammatory process in autoimmune uveitis.

  2007cites this paper
• Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation

  2007cites this paper
• Application of two-dimensional electrophoresis in the research of retinal proteins of diabetic rat.

  2007cites this paper
• Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy

  2007cites this paper
• Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients

  2007cites this paper
• Differentially-expressed glycoproteins in Locusta migratoria hemolymph infected with Metarhizium anisopliae.

  2007cites this paper
• Identification of Biomarkers for Type 2 Diabetes and Its Complications: A Bioinformatic Approach

  2007cites this paper
• Comparative Proteome Analysis of Neural Retinas from Type 2 Diabetic Rats by Two-dimensional Electrophoresis

  2007cites this paper
• Differenzielle Expression von Proteinen im Glaskörper gesunder und an ERU erkrankter Pferde

  2007cites this paper
• Down‐regulation of pigment epithelium‐derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood‐retinal barrier

  2007cites this paper
• A Role for Excitatory Amino Acids in Diabetic Eye Disease

  2007cites this paper
• Detection of Elevated Signaling Amino Acids in Human Diabetic Vitreous by Rapid Capillary Electrophoresis

  2007cites this paper
• Proteomics in ocular fluids

  2007cites this paper
• Proteomics for diabetes research: an update and future perspectives

  2006cites this paper